ASTH vs. ULS, RDDT, STN, CART, GLOB, HQY, BILI, ETSY, QXO, and TNET
Should you be buying Astrana Health stock or one of its competitors? The main competitors of Astrana Health include UL Solutions (ULS), Reddit (RDDT), Stantec (STN), Maplebear (CART), Globant (GLOB), HealthEquity (HQY), Bilibili (BILI), Etsy (ETSY), QXO (QXO), and TriNet Group (TNET). These companies are all part of the "business services" industry.
Astrana Health (NASDAQ:ASTH) and UL Solutions (NYSE:ULS) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, community ranking, risk, media sentiment and profitability.
In the previous week, UL Solutions had 3 more articles in the media than Astrana Health. MarketBeat recorded 6 mentions for UL Solutions and 3 mentions for Astrana Health. UL Solutions' average media sentiment score of 1.14 beat Astrana Health's score of 0.98 indicating that UL Solutions is being referred to more favorably in the news media.
Astrana Health has a net margin of 4.30% compared to UL Solutions' net margin of 0.00%. Astrana Health's return on equity of 10.71% beat UL Solutions' return on equity.
Astrana Health presently has a consensus target price of $59.00, suggesting a potential upside of 23.85%. UL Solutions has a consensus target price of $43.90, suggesting a potential downside of 9.63%. Given Astrana Health's stronger consensus rating and higher possible upside, analysts plainly believe Astrana Health is more favorable than UL Solutions.
52.8% of Astrana Health shares are held by institutional investors. 8.5% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
UL Solutions received 6 more outperform votes than Astrana Health when rated by MarketBeat users. However, 88.89% of users gave Astrana Health an outperform vote while only 70.00% of users gave UL Solutions an outperform vote.
UL Solutions has higher revenue and earnings than Astrana Health.
Summary
Astrana Health beats UL Solutions on 9 of the 16 factors compared between the two stocks.
Get Astrana Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for ASTH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Astrana Health Competitors List
Related Companies and Tools